Mary Ann Gray - Insider Trading & Ownership

Entity
Individual
Location
201 W 70 Th St, Suite 23 K, New York, NY
Summary
The estimated net worth of Mary Ann Gray is at least $1.35M dollars as of June 14, 2024. Mary Ann Gray is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $993K. Mary Ann Gray is the Director of RAPT Therapeutics, Inc. and owns shares of RAPT Therapeutics, Inc. (RAPT) stock worth about $277K. Mary Ann Gray is the Director of BioAtla, Inc. and owns shares of BioAtla, Inc. (BCAB) stock worth about $81.4K. Mary Ann Gray is the Director of PALISADE BIO, INC. and owns shares of PALISADE BIO, INC. (PALI) stock worth about $2.97K.
All Insider Reports
All Insider Reports

Ownership of Mary Ann Gray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. Director $993K Mar 7, 2022
RAPT RAPT Therapeutics, Inc. Director $277K May 22, 2024
BCAB BioAtla, Inc. Director $81.4K Jun 13, 2024
PALI PALISADE BIO, INC. Director $2.97K Nov 21, 2023
CMPX Compass Therapeutics, Inc. Director Feb 9, 2024
KROS Keros Therapeutics, Inc. Director May 30, 2024

Insider Transactions Reported by Mary Ann Gray:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.